A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition

Wiley, British Journal of Pharmacology, 5(169), p. 1024-1034, 2013

Journal article published in 2013 by Y. Kobayashi, H. Wada, C. Rossios

, D. Takagi, C. Charron, P. J. Barnes, K. Ito

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by